PLRX logo

Pliant Therapeutics (PLRX) Company Overview

Profile

Full Name:

Pliant Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 3, 2020

Indexes:

Not included

Description:

Pliant Therapeutics (PLRX) is a biotechnology company focused on developing innovative treatments for fibrotic diseases. They use their proprietary technology to discover and advance therapies that target the underlying causes of these conditions, aiming to improve patient outcomes and quality of life.

Events Calendar

Earnings

Next earnings date:

May 6, 2025

Recent quarterly earnings:

Mar 3, 2025

Recent annual earnings:

Mar 3, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 4, 25 Wells Fargo
Equal-Weight
Mar 4, 25 RBC Capital
Sector Perform
Mar 4, 25 Needham
Hold
Mar 4, 25 HC Wainwright & Co.
Neutral
Mar 4, 25 Citigroup
Neutral
Mar 3, 25 Leerink Partners
Market Perform
Feb 14, 25 Needham
Buy
Feb 14, 25 HC Wainwright & Co.
Neutral
Feb 10, 25 Wells Fargo
Equal-Weight
Feb 10, 25 RBC Capital
Sector Perform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Pliant Therapeutics?
  • Does Pliant Therapeutics pay dividends?
  • What sector is Pliant Therapeutics in?
  • What industry is Pliant Therapeutics in?
  • What country is Pliant Therapeutics based in?
  • When did Pliant Therapeutics go public?
  • Is Pliant Therapeutics in the S&P 500?
  • Is Pliant Therapeutics in the NASDAQ 100?
  • Is Pliant Therapeutics in the Dow Jones?
  • When was Pliant Therapeutics's last earnings report?
  • When does Pliant Therapeutics report earnings?
  • Should I buy Pliant Therapeutics stock now?

What is the ticker symbol for Pliant Therapeutics?

The ticker symbol for Pliant Therapeutics is NASDAQ:PLRX

Does Pliant Therapeutics pay dividends?

No, Pliant Therapeutics does not pay dividends

What sector is Pliant Therapeutics in?

Pliant Therapeutics is in the Healthcare sector

What industry is Pliant Therapeutics in?

Pliant Therapeutics is in the Biotechnology industry

What country is Pliant Therapeutics based in?

Pliant Therapeutics is headquartered in United States

When did Pliant Therapeutics go public?

Pliant Therapeutics's initial public offering (IPO) was on June 3, 2020

Is Pliant Therapeutics in the S&P 500?

No, Pliant Therapeutics is not included in the S&P 500 index

Is Pliant Therapeutics in the NASDAQ 100?

No, Pliant Therapeutics is not included in the NASDAQ 100 index

Is Pliant Therapeutics in the Dow Jones?

No, Pliant Therapeutics is not included in the Dow Jones index

When was Pliant Therapeutics's last earnings report?

Pliant Therapeutics's most recent earnings report was on Mar 3, 2025

When does Pliant Therapeutics report earnings?

The next expected earnings date for Pliant Therapeutics is May 6, 2025

Should I buy Pliant Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions